Goldenberg Alina, Ortiz Arisa, Kim Silvia S, Jiang S Brian
University of California, San Diego School of Medicine, La Jolla, California.
Division of Dermatology, University of California, San Diego, La Jolla, California.
J Am Acad Dermatol. 2015 Jul;73(1):120-6. doi: 10.1016/j.jaad.2015.02.1131. Epub 2015 Apr 1.
Squamous cell carcinoma with aggressive subclinical extension (SCC-ASE) is a tumor whose extensive spread becomes revealed during surgery or pathologic review, particularly during Mohs micrographic surgery. Limited clinical awareness of these lesions may result in unanticipated longer surgical times and larger postoperative defects. SCC-ASE-associated clinical risk factors are not well studied.
We sought to evaluate the incidence of and risk factors associated with SCC-ASE.
We conducted a retrospective analysis of SCC treated with Mohs micrographic surgery between 2007 and 2012 at a single academic surgical center. SCC-ASE was defined as a lesion requiring at least 3 Mohs stages with a final surgical margin of ≥1 cm.
Of 954 cases studied, 31% were SCC-ASE. In multivariable analysis, sex (P = .001), history of previous nonmelanoma skin cancer (P < .001), Fitzpatrick skin types II and III (P = .004 and <.001, respectively), immunosuppression related to solid organ transplant (P < .001), and cigarette use (P < .001) were significant predictors of SCC-ASE.
Single academic center selection bias, not-controlled for sun exposure differences, no information on medication regimens of solid organ transplant patients, and a small sample size are all limitations of our study.
Easily attainable demographic factors, especially immunosuppressed status and cigarette use, can help predict the occurrence of SCC-ASE and thereby optimize surgical planning and patient preparedness.
具有侵袭性亚临床扩展的鳞状细胞癌(SCC-ASE)是一种肿瘤,其广泛扩散在手术或病理检查期间,特别是在莫氏显微外科手术期间才被发现。对这些病变的临床认识有限可能导致意外的更长手术时间和更大的术后缺损。SCC-ASE相关的临床风险因素尚未得到充分研究。
我们试图评估SCC-ASE的发病率及其相关风险因素。
我们对2007年至2012年在一个学术性外科中心接受莫氏显微外科手术治疗的SCC进行了回顾性分析。SCC-ASE被定义为一个病变至少需要3个莫氏阶段,最终手术切缘≥1厘米。
在研究的954例病例中,31%为SCC-ASE。在多变量分析中,性别(P = .001)、既往非黑色素瘤皮肤癌病史(P < .001)、菲茨帕特里克皮肤类型II和III(分别为P = .004和<.001)、与实体器官移植相关的免疫抑制(P < .001)以及吸烟(P < .001)是SCC-ASE的显著预测因素。
单一学术中心选择偏倚、未控制阳光暴露差异、没有实体器官移植患者药物治疗方案的信息以及样本量小都是我们研究的局限性。
易于获得的人口统计学因素,特别是免疫抑制状态和吸烟,可以帮助预测SCC-ASE的发生,从而优化手术规划和患者准备。